Kamuvudine-9 and Multiple Sclerosis
Multiple sclerosis research has produced an intriguing new development following the publication of a study involving an experimental medicine called kamuvudine-9, also known as K-9. Researchers have reported that K-9 was able not only to prevent further neurological deterioration in a laboratory model of multiple sclerosis but also to reverse existing paralysis and vision loss in mice.